Print Page | Sign In | Join
Business Wire Life Sciences News (US)
Share |

Certara Launches COVID-19 Pharmacology Online Resource CenterOpen in a New Window

PRINCETON, N.J.--(BUSINESS WIRE)--Certara has launched the COVID-19 Pharmacology Resource Center, funded by the Bill & Melinda Gates Foundation, to help advance COVID-19 therapeutics.


Relief Therapeutics (RLF:SIX) Drug Aviptadil Enters FDA Trial at University of Miami, to Treat COVID-19-induced Respiratory DistressOpen in a New Window

GENEVA--(BUSINESS WIRE)--Relief Therapeutics drug Aviptadil enters FDA trial at University of Miami, to treat COVID-19-induced Respiratory Distress


Lattice Biologics Signs Definitive Agreement with Alumina Partners for $6 Million At-Will Offering FacilityOpen in a New Window

BELGRADE, Mont.--(BUSINESS WIRE)--Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) is pleased to announce that it has entered into a definitive agreement (the "Agreement") with Alumina Partners (Ontario) Ltd. ("Alumina") for a commitment of up to $6,000,000 CDN (six million dollars) in an at-will offering facility (the "Facility"). This facility replaces the previously announced private placement announced on March 17th, 2020. Pursuant to the terms of th


IQVIA Launches First Technology-Enabled COVID-19 Trial Matching Solution within the U.S. to Accelerate Treatment and Vaccine DevelopmentOpen in a New Window

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV), a leader in Human Data Science, today announced its new technology-enabled COVID-19 Trial Matching Tool at, which is one of the world’s first online platforms that matches individuals with specific COVID-19 studies to accelerate clinical research projects. “In response to this unprecedented crisis, IQVIA has created the first comprehensive online screener and trial matching tool for all U.S. COVID-


3M and the Trump Administration Announce Plan to Import 166.5 Million Additional Respirators into the United States over the Next Three MonthsOpen in a New Window

ST. PAUL, Minn.--(BUSINESS WIRE)--Today 3M and the Trump Administration are announcing a plan to import 166.5 million respirators over the next three months to support healthcare workers in the United States. 3M and the Administration worked together to ensure that this plan does not create further humanitarian implications for countries currently fighting the COVID-19 outbreak, and committed to further collaborate to fight price gouging and counterfeiting. “I want to thank President Trump and


NBA All-Star Joel Embiid Makes Significant Contribution to #FirstRespondersFirst, Further Demonstrating His Commitment to Supporting Healthcare Workers on the Frontlines of the COVID-19 PandemicOpen in a New Window

PHILADELPHIA--(BUSINESS WIRE)-- #firstrespondersfirst--Last month, in response to the Coronavirus outbreak in the United States, three-time NBA All-Star Joel Embiid pledged to donate $500,000 to support medical relief efforts for COVID-19. A longstanding believer in “The Process,” Embiid has spent the past two weeks researching the most efficient ways to provide immediate aid to healthcare workers serving on the frontlines. Today, Embiid announced that he has identified #FirstRespondersFirst, an initiative of Harvard


HilltopSecurities Supports Hospitals in Fight Against COVID-19Open in a New Window

DALLAS--(BUSINESS WIRE)--The coronavirus pandemic has caused serious financial stress on our public health systems and placed a significant burden on hospitals caring for the influx of patients with COVID-19. In support of our healthcare system, Hilltop Securities Inc. (HilltopSecurities) is offering to provide financial advisory services related to addressing the financial consequences of the coronavirus pandemic at no charge for any community-based hospital with 75 beds or less in Oklahoma, N


IWBI Announces New Co-chairs and More than 225 Members of the Task Force on COVID-19 and Other Respiratory Infections: Prevention and Preparedness, Resilience and RecoveryOpen in a New Window

NEW YORK--(BUSINESS WIRE)-- #WeAreWELL--The International WELL Building Institute (IWBI) today announced the addition of four renowned industry, academic and public health leaders from the U.S., United Kingdom, China and Singapore as the newest co-chairs of its Task Force on COVID-19 and other Respiratory Infections: Prevention and Preparedness, Resilience and Recovery. They join expert co-chairs from the U.S. and others from China who will help define the critical role buildings, organizations and communit


Global Payments Provides Business Update Related to COVID-19Open in a New Window

ATLANTA--(BUSINESS WIRE)--Global Payments Inc. (NYSE: GPN), a leading worldwide provider of payment technology and software solutions, today provided a business update as the impact of the coronavirus (COVID-19) continues to evolve. Global Payments is closely monitoring the impact of the COVID-19 outbreak and our top priority is to ensure the health and safety of our team members, customers, partners and the communities in which we live and work. We have taken numerous actions to safeguard our


HCA Healthcare Teams With Google Cloud and SADA on Data Portal to Help Communities Respond to COVID-19Open in a New Window

NASHVILLE, Tenn. & SUNNYVALE, Calif. & LOS ANGELES--(BUSINESS WIRE)--HCA Healthcare (NYSE:HCA), one of the nation’s leading healthcare providers, and Google Cloud today jointly announced the COVID-19 National Response Portal, an open data platform built and operated by SADA. Running on Google Cloud, the platform is intended to promote data-sharing about the COVID-19 pandemic and how it is spreading in an effort to help hospitals and communities prepare and respond. “COVID-19 presents a unique a


Allied Esports Adds HyperX to New Online Tournament OfferingOpen in a New Window

IRVINE, Calif.--(BUSINESS WIRE)--Allied Esports has teamed up with a familiar face for its new online tournament offering – HyperX. Starting this week, the gaming peripheral and technology company will officially present the Allied Esports Online Tournament schedule and broadcasts. Allied Esports Online Tournaments Presented by HyperX are open to all levels of play and offer cash and/or HyperX products as prizing for each competition. Tournament fees are dependent on the game, with some competi


Ralph Lauren Corporation Provides Business Update on COVID-19Open in a New Window

NEW YORK--(BUSINESS WIRE)--Ralph Lauren Corporation Provides Business Update on COVID-19


GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)Open in a New Window

ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (the “Company”) (NASDAQ:GLYC) today announced that the compensation committee of the Company’s Board of Directors approved the grant on April 1, 2020 of non-qualified stock option awards to purchase an aggregate of 40,600 shares of its common stock to two new employees. The options were granted as inducement equity awards outside of the Company’s 2013 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4), and were made as an


NanoString Provides COVID-19 Business Update and Announces Conference Call on Thursday May 7th, 2020Open in a New Window

SEATTLE--(BUSINESS WIRE)--NanoString provides COVID-19 business update.


Supplement Industry Associations Applaud FDA Actions to Protect Consumers from Fraudulent Products Related to Coronavirus Disease (COVID-19)Open in a New Window

WASHINGTON--(BUSINESS WIRE)--The U.S. dietary supplement industry commends the Food and Drug Administration (FDA) for taking action to protect consumers by calling out marketers who make illegal and unsubstantiated drug claims related to COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2. In February, the industry issued strong warning to companies and consumers to avoid marketing or using dietary supplements that are presented as treating, curing or preventing COVID-19. Since th


Convalescent Plasma Collected in the CarolinasOpen in a New Window

GREENVILLE, S.C.--(BUSINESS WIRE)-- #blooddonor--The Blood Connection (TBC) has announced that it is collecting donations from recovered COVID-19 patients to help with research and clinical trials. The blood product, known as convalescent plasma, may have antibodies that can help those critically ill from COVID-19 to fight the virus. In a recent release the CEO of America’s Blood Centers, Kate Fry said, "This promising investigational product must get to patients without delay, and blood centers across the c


iBIO Commends Illinois the Life Sciences Community for its Impact through the iBIO COVID-19 PPE Response FundOpen in a New Window

CHICAGO--(BUSINESS WIRE)--iBIO today announced that since the March 23rd launch of the iBIO COVID-19 PPE Response Fund, the Illinois life sciences community is making a significant impact in the fight against the coronavirus. As of this morning, the fund has received more than $760,000 in cash contributions and thousands of donated supplies. iBIO is directing monetary donations to its BIO Business Solutions lab supply partner, which places ongoing orders for personal protective equipment (PPE)


National Geographic Launches NatGeo@Home Digital Hub to Support Families and Educators During COVID-19Open in a New Window

WASHINGTON--(BUSINESS WIRE)--As the coronavirus global pandemic has resulted in widespread school closures and stay-at-home mandates, National Geographic is responding to the needs of families and educators with NatGeo@Home, a centralized digital resource for families looking to fill the gap with practical, educational, inspiring and entertaining content designed to keep families connected to the natural world and the science behind it. NatGeo@Home, available for free during these trying times,


TTN Fleet Solutions - Offers Decontamination Services to FleetsOpen in a New Window

ARGYLE, Texas--(BUSINESS WIRE)-- #Maintenance--As the trucking industry ramps up its essential service to consumers, health and safety concerns loom large for drivers on the road and the logistics professionals that must keep freight moving, despite the proven benefits of social distancing. As of April 6th, more than 330,000 COVID-19 cases have been confirmed in the United States, and more than 10,000 of those cases have ended in fatality. Many companies across the industry, therefore, are pivoting service of


CORRECTING and REPLACING Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune TherapyOpen in a New Window

OSAKA, Japan & KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions to the Octapharma boilerplate and inclusion of additional multimedia. GLOBAL PLASMA LEADERS COLLABORATE TO ACCELERATE DEVELOPMENT OF POTENTIAL COVID-19 HYPERIMMUNE THERAPY Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19 Biotest, BPL, LFB, a


EKIMAS Corporation Announces Special Cash DistributionOpen in a New Window

CANTON, Mass.--(BUSINESS WIRE)--EKIMAS Cash Distribution


CORRECTING and REPLACING and the State of Texas Partner to Provide Access to Childcare for Frontline Workers Across the State During COVID-19 PandemicOpen in a New Window

WALTHAM, Mass.--(BUSINESS WIRE)--Second paragraph, URL of release should read: (instead of The corrected release reads: CARE.COM AND THE STATE OF TEXAS PARTNER TO PROVIDE ACCESS TO CHILDCARE FOR FRONTLINE WORKERS ACROSS THE STATE DURING COVID-19 PANDEMIC To address the growing need for childcare solutions for Texas frontline workers during the coronavirus pandemic, announced today that it is partnering with Governor Greg Abb


Milken Institute Global Conference Rescheduled to OctoberOpen in a New Window

LOS ANGELES--(BUSINESS WIRE)-- #conference--The Milken Institute announced today that the 2020 Milken Institute Global Conference will be held October 12-15, 2020. It had been scheduled to take place July 7-10 after the Milken Institute postponed the original dates of May 3-6, 2020. These new dates were selected after evaluating public guidelines and in consultation with partners in government, medical research, and the private sector. The 23rd annual event, which brings together international leaders in bus


Analog Devices Contributes to Global Fight Against COVID-19Open in a New Window

NORWOOD, Mass.--(BUSINESS WIRE)--Analog Devices Contributes to Global Fight Against COVID-19


AM Best to Host Webinar on COVID-19 Implications for U.S. Insurance and Reinsurance MarketsOpen in a New Window

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best will host a complimentary webinar, on April 9, 2020, at 10 a.m. (EDT). AM Best analysts will review the changing impact of COVID-19 on AM Best’s U.S. insurance sector and global reinsurance outlooks, as well as discuss additional rating considerations. Register now at Panelists from AM Best Rating Services include: Stefan Holzberger, chief rating officer, AM Best (moderator); Carlos Wong-Fupuy, senior director, AM Best; Sa


Xerox and Vortran Medical Partnering to Mass Produce Disposable VentilatorsOpen in a New Window

NORWALK, Conn. & SACRAMENTO, Calif.--(BUSINESS WIRE)---- $XRX--Xerox Holdings Corporation (NYSE: XRX) and Vortran Medical Technology are teaming up to speed and scale production of Vortran’s GO2Vent ventilator.


Taro Appoints New Chief Financial OfficerOpen in a New Window



PAN Foundation Launches COVID-19 Treatment and Prevention Fund to Help At-Risk Medicare Beneficiaries Pay for Treatment, Groceries and Other Critical ServicesOpen in a New Window

WASHINGTON--(BUSINESS WIRE)--The PAN Foundation, an independent charitable organization dedicated to helping underinsured patients access critical medical care, today announced that it will offer financial assistance to Americans with existing medical conditions who have COVID-19 or are quarantined because of the virus. Through this comprehensive fund, PAN will provide a $300 grant to qualifying Medicare beneficiaries with cancer, chronic or rare diseases who have also been diagnosed with COVID


Hope Biosciences Receives FDA Approval to Commence First Stem Cell Clinical Trial for Protection Against COVID-19Open in a New Window

HOUSTON--(BUSINESS WIRE)-- #COVID19--Hope Biosciences Receives FDA Approval to Commence First Stem Cell Clinical Trial for Protection Against COVID-19.


Learning from Times of Uncertainty: HR’s Critical Role in Business ContinuityOpen in a New Window

LOWELL, Mass.--(BUSINESS WIRE)-- #HCM--Kronos presents educational webinar on to support HR professionals guiding business continuity during times of uncertainty.


Chemical Insights Partners With Duke University to Research Air Pollution Impacts on Asthmatic ChildrenOpen in a New Window

ATLANTA--(BUSINESS WIRE)--Chemical Insights, an Institute of Underwriters Laboratories, announced today the findings from its research collaboration with Duke University on the influence of outdoor and indoor air pollution on asthmatic children was published in JAMA Pediatrics, a journal of the American Medical Association. This study is the first to document that physiological improvements occur in children’s small airways when air filters designed to trap ambient fine particulate matter (PM2.


Medable Allies With MRN to Support New Remote Care Capabilities Globally, Critical for Decentralized Clinical Trials and Continued Clinical Research Progress During COVID-19Open in a New Window

PALO ALTO, Calif.--(BUSINESS WIRE)-- #decentralizedtrials--Medable Inc., the leading global platform for decentralized clinical trials, and MRN today announced a global alliance to bring shared capabilities to decentralized clinical trials. Specifically, Medable will empower MRN’s home clinical trial specialists to conduct home and remote visits using Medable’s Trial-Fit Telemedicine solution to enable remote patient monitoring, medication administration, patient care, and clinical assessments. These capabilities are


 Bioasis Completes Redemption of 15% Unsecured Debentures With Unanimous Debentureholder ApprovalOpen in a New Window

GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”) a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced that it has completed its previo


HNI Corporation Provides Update Related to COVID-19 Coronavirus PandemicOpen in a New Window

MUSCATINE, Iowa--(BUSINESS WIRE)--HNI Corporation Provides Update Related to COVID-19 Coronavirus Pandemic


Cummins and DuPont Partner to Use Filter Technology to Supply Critical Material for N95 Respirator MasksOpen in a New Window

COLUMBUS, Ind.--(BUSINESS WIRE)--As the COVID-19 pandemic spreads across the globe, Cummins Inc. (NYSE: CMI) and DuPont (NYSE: DD) are helping address the nation’s shortage of N95 respirator masks. Cummins’ NanoNet® and NanoForce® Media technology, which uses DuPont’s Hybrid Membrane Technology (HMT), can typically be found in air, fuel and lube filtration products used in heavy-duty diesel engines to prevent long-term engine wear, but also can be used in the N95 respirator masks worn by health


U.S. Employees’ Biggest COVID-19 Fear Is Related to the Economy, JobsOpen in a New Window

CHICAGO--(BUSINESS WIRE)--ComPsych released today the results of its Tell It NowSM poll, asking employees what concerns them most about the coronavirus pandemic. Worries over the economy and jobs have now surpassed fears of contracting the virus itself, according to the poll. ComPsych Corporation is the world’s largest provider of employee assistance programs and is the pioneer and worldwide leader of fully integrated EAP, behavioral health, wellness, work-life, HR, FMLA and absence management


Lundbeck’s VYEPTI™ (eptinezumab-jjmr), Quarterly Treatment for Migraine Prevention in Adults, Now Available in U.S.Open in a New Window

DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck today announced that VYEPTI™ (eptinezumab-jjmr), is now commercially available in the U.S


Richland Community College Partners With META for Online Mental Health ServicesOpen in a New Window

BUFFALO GROVE, Ill.--(BUSINESS WIRE)--META, a teletherapy platform for online mental health services, provides students with confidential and easy access to mental wellness providers. Richland Community College has become the latest institution of higher learning to offer the META mental wellness program to students. In response to the COVID-19 outbreak, Richland Community College moved all classes online for the remainder of the spring semester. Richland students can download the free META mob


Website developer Five More Talents launches COVID-19 dashboard and online resources for churchesOpen in a New Window

DETROIT--(BUSINESS WIRE)-- #COVID19--Five More Talents COVID-19 dashboard gives churches tools and resources for online giving, video streaming and more during social distancing.


Deerfield Closes $840 Million Healthcare Venture FundOpen in a New Window

NEW YORK--(BUSINESS WIRE)--New Deerfield $840 million healthcare venture fund to invest in promising therapeutics and improvements to the delivery of healthcare.


Pulse Biosciences Files Registration Statement for Rights OfferingOpen in a New Window

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company”, or “Pulse Biosciences”) today announced that it filed a registration statement on Form S-3 with the Securities and Exchange Commission (the “SEC”) for a rights offering to its existing stockholders. The rights offering will be made through the distribution of non-transferable subscription rights to purchase shares of the Company’s common stock, par value $0.001 per share, at a subscription price to be dete


Experity Offers Complimentary Urgent Care Application for Treating COVID-19 PatientsOpen in a New Window

MACHESNEY PARK, Ill.--(BUSINESS WIRE)--Experity, the leading provider of electronic medical records (EMR) and practice management (PM) software in the urgent care space, announced it has released a COVID-19 Response Application, free for any U.S.-based urgent care clinic. The application’s functionality allows urgent care clinics to connect with patients virtually through two-way text messaging and telemedicine functionality to help with mitigating exposure for the community and clinic staff. I


Nonprofit Stupid Cancer Offers Lifeline to Young Adult Cancer Community Amid Coronavirus PandemicOpen in a New Window

NEW YORK--(BUSINESS WIRE)--Stupid Cancer, a nonprofit leader in the young adult cancer movement, announced plans to provide additional support amid COVID-19.


Invacare Corporation to Participate in the 19th Annual Needham Healthcare ConferenceOpen in a New Window

ELYRIA, Ohio--(BUSINESS WIRE)--Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE:IVC), will participate in a fireside chat at the 19th Annual Needham Healthcare Conference on Tuesday, April 14, 2020 at 9:20 a.m. ET. The live audio cast will be available at and it will be accessible for replay for 90 days following the conference. About Invacare Corporation Invacare Corporation is a leading manufacturer and distribu


Telidyne Announces New Mobile App for Detection of Coronavirus and Other Infectious DiseasesOpen in a New Window

NEW YORK--(BUSINESS WIRE)---- $TLDN #TLDN--Telidyne, Inc (the “Company”) (OTC: TLDN), an emerging technology company which already has a digital payment mobile App, TELIBIT (TELI) in the marketplace, announced today that it has started work on developing a new mobile app to be available globally on both iPhone and Android platforms that would allow easy detection of coronavirus (COVID-19) or other similar infectious diseases among global population. The Company has started the development work and expects to h


Lantheus Holdings, Inc. to Hold 2020 Annual Meeting of Stockholders VirtuallyOpen in a New Window

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--In response to continued public health concerns about in-person gatherings given the coronavirus/COVID-19 outbreak, the Board of Directors of Lantheus Holding, Inc. (the “Company”) (NASDAQ:LNTH) has determined to change the format of the company’s 2020 Annual Meeting of Stockholders scheduled for Thursday, April 23, 2020 at 11:00 a.m. (Eastern Time) from in-person to virtual-only. The meeting will be webcast and can be accessed by stockholders at


Tyme Technologies to Present at the 2020 Cross-Border Healthcare Webinar SeriesOpen in a New Window

NEW YORK--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the 2020 Cross-Border Healthcare Webinar Series on Tuesday, April 7, 2020. The Company will present its corporate overview with a focus on: Growth opportunities driven by advances in the science of cancer metabolism, Recently launched pivotal trials in pancreatic cancer and a Phase II trial in sarcom


American Family Insurance to Return $200 Million in Premium to Auto CustomersOpen in a New Window

MADISON, Wis.--(BUSINESS WIRE)--American Family Insurance to return $200 million in premium to auto customers.


Cerus Corporation Provides Update on COVID-19 Related ActivitiesOpen in a New Window

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq:CERS) today announced the Company’s recent activities related to COVID-19 and efforts to ensure that patients have readily available access to pathogen-reduced blood components, including convalescent plasma. “As the world endures the impact from the current COVID-19 pandemic, our focused mission of ensuring the availability and safety of the world’s blood supply has never been more relevant. The impact that this pandemic has had on th


Cortexyme to Present at the LifeSci Capital Alpha Series Virtual Conference on April 9, 2020Open in a New Window

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what it believes to be a key underlying cause of Alzheimer’s and other degenerative diseases, today announced Casey Lynch, the company’s chief executive officer, chair, and co-founder, will participate in a fireside chat at the virtual LifeSci Capital Alpha Series Conference on Thursday, April 9, 2020 at 1:00


Rite Aid to Release Fourth Quarter Results on April 16Open in a New Window

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2020 Fourth Quarter, which ended February 29, 2020, on Thursday, April 16, 2020. The company will hold an analyst call at 8:30 a.m. Eastern Time with remarks by Rite Aid's management team. The call will be broadcast via the Internet at The telephone replay will be available beginning at 12 p.m. East


spare Launches New Solution to Assist New Yorkers in CrisisOpen in a New Window

NEW YORK--(BUSINESS WIRE)--COVID-19 is shuttering businesses across New York City and shifting thousands off of grocery lines to food bank lines. In response, spare, a national non-profit, today announced a new feature inside its mobile application, called ‘spare hunger’, designed to support struggling families across the city. spare hunger rounds up its users’ take out and grocery orders to the next dollar, donating 100 percent of funds raised to Food Bank For New York City. “Food Bank For New


ProtoKinetix AAGP® Exhibits Efficacy and Safety in Model of Dry Eye DiseaseOpen in a New Window

MARIETTA, Ohio--(BUSINESS WIRE)-- #AAGP--ProtoKinetix AAGP® Exhibits Efficacy and Safety in Model of Dry Eye Disease


Copper Compression Donates 18,000 Reusable Copper-Infused Masks to New York/New Jersey Metro-Area Health Systems to Aid in Fight Against COVID-19Open in a New Window

NEW YORK--(BUSINESS WIRE)-- #CopperCompressionDonates18000masks--Copper Compression Donates 18,000 Reusable Copper-Infused Masks to New York/New Jersey Metro-Area Health Systems to Aid in Fight Against COVID-19


Pfizer and The Pfizer Foundation Donate $40 Million in Charitable Grants, Expand Product Access and Mobilize Colleagues to Combat COVID-19 PandemicOpen in a New Window

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and The Pfizer Foundation today announced the commitment of $40 million in medical and charitable cash grants to help combat the global health effects of the COVID-19 pandemic in the U.S. and around the world. The donation addresses the urgent needs of partners who are working to slow the spread of the virus within communities and strengthen vulnerable healthcare systems against future public health threats. Pfizer is also responding to patient


Calpine Corporation Announces Community Support Efforts and Provides COVID-19 Operational and Financial UpdateOpen in a New Window

HOUSTON--(BUSINESS WIRE)--As the COVID-19 virus continues to significantly impact life in the United States and globally, we at Calpine Corporation have implemented a robust business continuity plan to ensure the safety of our employees and communities within which we operate, while maintaining continued reliable operations at our generating facilities. “We are clearly in unprecedented and difficult times. Despite the challenges that the COVID-19 outbreak presents, our employees are staffing ou


Assurance and ClearView Support the BCI’s Upcoming Pandemic ReportOpen in a New Window

AUDUBON, Pa. & OXFORDSHIRE, England--(BUSINESS WIRE)-- #BusinessContinuity--Assurance and ClearView will be sponsoring a survey from the BCI, which will inform a new report exploring current pandemic planning activities.


Bigfinite Announces Senior Leadership AdditionsOpen in a New Window

SAN FRANCISCO--(BUSINESS WIRE)-- #AI--Bigfinite, Inc. (Bigfinite), the leading manufacturing data analytics platform company for regulated industries, today announced that John Vitalie has been named Chief Executive Officer (CEO) and has been elected to the Board of Directors. David Merino has been named Chief Financial Officer (CFO) of Bigfinite. Other recent additions to the Bigfinite leadership team include Crystal Black, VP of Marketing; Cristian Marfà, VP of Technical Sales; and Daniel Voicu, VP


AVITA Medical Provides Preliminary Top Line Results for the Third Quarter and COVID-19 UpdateOpen in a New Window

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical Provides Preliminary Top Line Results for the Third Quarter and COVID-19 Update


PolarityTE Announces the Addition of Audit Executive Chris Nolet to Board of DirectorsOpen in a New Window

SALT LAKE CITY--(BUSINESS WIRE)--PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced the appointment of Chris Nolet to the Company’s Board of Directors and Chair of the Audit Committee. Mr. Nolet brings extensive audit and business experience with nearly forty years in the profession, most recently as the West Region Life Sciences Industry Leader and Partner at EY. Prior to EY, Mr. Nolet spent over


Endologix Announces Preliminary Financial Results for First Quarter 2020Open in a New Window

IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that its preliminary unaudited revenue for the first quarter ended March 31, 2020 is expected to be approximately $28.5 million. Total cash, cash equivalents, and restricted cash as of March 31, 2020 are expected to be approximately $42.4 million, including approximately $10.5 million outstanding under the Company’s revolving cr


Sema4 Launches High-Capacity COVID-19 Testing to Address Critical Need Across Connecticut and New YorkOpen in a New Window

STAMFORD, Conn.--(BUSINESS WIRE)-- #COVID19--Sema4 is partnering with the state of Connecticut and regional healthcare providers to address the pressing need for high-throughput COVID-19 testing


Hilton and American Express to Donate Up to 1 Million Rooms To Frontline Medical Professionals During COVID-19 CrisisOpen in a New Window

MCLEAN, Va. & NEW YORK--(BUSINESS WIRE)--Hilton (NYSE:HLT) and American Express (NYSE:AXP) today announced that the companies, in partnership with Hilton’s ownership community, will donate up to 1 million hotel room nights across the United States to frontline medical professionals leading the fight against COVID-19. Beginning next week, Hilton and American Express will make rooms available without charge to doctors, nurses, EMTs, paramedics and other frontline medical staff who need a place to


European Commission Approves Takeda’s ALUNBRIG® (brigatinib) as a First-Line Treatment for ALK+ NSCLCOpen in a New Window

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) extended the current marketing authorization of ALUNBRIG (brigatinib) to include use as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously not treated with an ALK inhibitor. This decision follows a positive opinion from the Committee for M


Owens & Minor Announces Location Change for its 2020 Annual Meeting of ShareholdersOpen in a New Window

RICHMOND, Va.--(BUSINESS WIRE)---- $OMI #OMI--Owens & Minor Announces Location Change for its 2020 Annual Meeting of Shareholders; Annual Meeting to be webcast in virtual-only format


Free Accelerated Data Transfer Software for COVID-19 ResearchersOpen in a New Window

BOSTON--(BUSINESS WIRE)-- #datatransport--Data Expedition, Inc. offers free licenses of its accelerated data transport software to scientific researchers fast-tracking research on COVID-19.


LFB Announces FDA Approval of SEVENFACT®, a New Recombinant Coagulation Factor VIIa, for the Treatment of Adults and Adolescents with Hemophilia A or B with InhibitorsOpen in a New Window

LES ULIS, France--(BUSINESS WIRE)--LFB today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) 2061 for SEVENFACT®, a new recombinant coagulation Factor VIIa [coagulation factor VIIa (recombinant)-jncw], for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with Hemophilia A or B with inhibitors (neutralizing antibodies). An exclusive license for the commercialization of the pr


Seres Therapeutics Appoints Lisa von Moltke, M.D., as Chief Medical OfficerOpen in a New Window

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $MCRB--Dr. Lisa von Moltke joins as CMO of Seres with an extensive career that includes senior leadership positions at Alkermes and Sanofi Genzyme.


Alnylam and Dicerna Form RNAi Therapeutics Collaboration on Alpha-1 Antitrypsin Deficiency-Associated Liver Disease and Complete Cross-License Agreement for Primary Hyperoxaluria ProgramsOpen in a New Window

CAMBRIDGE, Mass. & LEXINGTON, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), and Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), both leaders in the field of ribonucleic acid interference (RNAi) therapeutics, announced today the formation of a development and commercialization collaboration on investigational RNAi therapeutics for the treatment of alpha-1 antitrypsin (A1AT) deficiency-associated liver disease (alpha-1 liver disease). In addition, the companies have complete


Ligand Provides a Corporate Update and Announces May 6th as the Date for First Quarter Earnings CallOpen in a New Window

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) provides a general corporate update, as follows: “As the business environment has evolved in response to the pandemic, Ligand has remained sharp with our operations and our partners have been highly productive over the past few weeks,” said John Higgins, Chief Executive Officer of Ligand Pharmaceuticals. “Last week we completed an acquisition, we just signed a deal for a novel FAAH inhibitor out of our Vernalis unit,


AlloVir Appoints Ugo Capolino Perlingieri Head of Europe and Middle East OperationsOpen in a New Window

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AlloVir, a late-clinical stage T-cell immunotherapy company, today announced that Ugo Capolino Perlingieri has been appointed to the newly created position of General Manager of Europe and Middle East operations. In this role, he will be responsible for implementing clinical and commercial programs to pave the way for regulatory review and eventual commercialization of the company’s full range of investigational T-cell therapies. “Ugo is an outstanding leader


Castle Biosciences to Present at the 19th Annual Needham Virtual Healthcare ConferenceOpen in a New Window

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle is scheduled to present at the 19th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2020, at 3:30 p.m. Eastern.


Insulet to Announce First Quarter 2020 Financial Results on May 7, 2020Open in a New Window

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced plans to release its financial results for the first quarter of 2020 on May 7, 2020 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time). The link to the live call will be available on the Invest


Crisis Pharmacy-Finding Tool Launches Nationally Amid COVID-19 Related Service InterruptionsOpen in a New Window

WASHINGTON--(BUSINESS WIRE)--In response to ongoing COVID-19 pandemic-related healthcare disruptions, Rx Open, an online resource for finding open pharmacies and dialysis facilities, has been activated nationwide by Healthcare Ready, a preparedness and response nonprofit working with public and private sectors to strengthen healthcare systems before, during, and after disasters. Until this week, Rx Open has only been used during hurricanes, fires, and other natural disasters; for the first time


Millendo Therapeutics Announces Topline Results for Pivotal Phase 2b Study of Livoletide in Patients with Prader-Willi Syndrome (PWS)Open in a New Window

ANN ARBOR, Mich.--(BUSINESS WIRE)--Millendo Therapeutics Announces Topline Results for Pivotal Phase 2b Study of Livoletide in Patients with Prader-Willi Syndrome (PWS)


Bicycle Therapeutics to Participate in a Panel Discussion at the Canaccord Genuity Horizons in Oncology ConferenceOpen in a New Window

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycles®) technology, today announced that management will participate in a panel discussion on bispecifics at the Canaccord Genuity Horizons in Oncology Conference on Wednesday, April 8, 2020 at 10:15 a.m. ET. The conference will be held in a virtual meeting format. A live webcast of


AECOM supporting the U.S. Army Corps of Engineers' work on a temporary medical facility in New York to assist with the region’s coronavirus pandemic recovery effortsOpen in a New Window

NEW YORK--(BUSINESS WIRE)--AECOM (NYSE:ACM), the world’s premier infrastructure firm, today announced that it is supporting the U.S. Army Corps of Engineers (USACE), New York District, with design and construction management services to transform a university facility on Long Island into a temporary medical facility with more than 1,000 beds. In support of a FEMA mission, the alternate care facility at the State University of New York, College at Old Westbury will help ease the strain on existi


Kontoor Brands to Produce and Supply Patient and Disposable Isolation Gowns to Hospitals in Response to COVID-19 PandemicOpen in a New Window

GREENSBORO, N.C.--(BUSINESS WIRE)---- $KTB #WeAreKontoor--Kontoor Brands, Inc. (NYSE: KTB), a global lifestyle apparel company, with a portfolio led by two of the world’s most iconic consumer brands, Wrangler® and Lee®, today announced that it has begun producing approximately 50,000 Level 1 patient gowns and 10,000 disposable isolation gowns for clinicians to assist hospitals that are dealing with the influx of patients as a result of the COVID-19 coronavirus pandemic. “In times like these, it’s important that we al


Magellan Health Appoints Tim Lacy as Chief Growth OfficerOpen in a New Window

PHOENIX--(BUSINESS WIRE)--Magellan Health has appointed Tim Lacy as Chief Growth Officer.


Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug DiscoveryOpen in a New Window

FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Second Genome, a leader in microbiome science, today announced that the companies have entered into a four-year strategic collaboration to identify biomarkers associated with clinical response in up to five of Gilead’s pipeline compounds in inflammation, fibrosis and other diseases, and to identify potential new targets and drug candidates for the treatment of inflammatory bowel disease


Axonics® Submits PMA Supplement to U.S. Food & Drug Administration to Expand Full-Body MRI Labeling for 3T ScansOpen in a New Window

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today announced the submission of a premarket approval (“PMA”) supplement to the U.S. Food & Drug Administration (“FDA”) for the purpose of gaining full-body magnetic resonance imaging (“MRI”) conditional labeling for 3.0T MRI s


United States and EU5 Critical Care Patient Monitoring Market to 2024 - Drivers, Restraints and Trends - ResearchAndMarkets.comOpen in a New Window

DUBLIN--(BUSINESS WIRE)--The "Analysis of the Critical Care Patient Monitoring Market, US and EU5, Forecast to 2024" report has been added to's offering. The economic burden for global critical care is estimated at $270 billion and intensive care unit (ICU) mortality in developed countries is still in the range of 10% to 20%. Advancements in effective patient monitoring in the ICU can not only help reduce the mortality rate but also be beneficial in improving patient and


About BioFlorida

BioFlorida represents 6,200 establishments and research organizations in the biopharmaceuticals, medical technology, healthIT and bioagriculture sectors that collectively employ 87,000 Floridians.


Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.


NEW regional sponsorship opportunities available.